CD68 and hepatocellular carcinoma: This may explain observations where overexpression of CD68+ TAMs was associated with poor overall survival and disease-free survival (DFS) in breast cancer patients (32), whereas conversely, high CD68+ TAM expression conferred a longer overall survival and disease-free survival in hepatocellular carcinoma patients (33).